Efficacy and Safety of Botulinum Toxin at Moderate to Severe Glabellar Lines
NCT04830345 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 290
Last updated 2022-04-04
Summary
Efficacy and safety of ATGC-100 are assessed in subjects with moderate to severe glabellar lines.
Conditions
- Glabellar Frown Lines
Interventions
- BIOLOGICAL
-
ATGC-100 100U
Clostridium botulinum toxin type A
- BIOLOGICAL
-
Botox 100U
Clostridium botulinum toxin type A
Sponsors & Collaborators
-
EuBiologics Co.,Ltd
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-06-29
- Primary Completion
- 2021-09-01
- Completion
- 2021-10-01
Countries
- South Korea
Study Locations
More Related Trials
-
A Study to Evaluate Sequential Administration of AGN-151586 and OnabotulinumtoxinA (BOTOX) Injections in Adult Participants for Treatment of Glabellar Lines
NCT05496335 ·Status: COMPLETED ·Phase: PHASE1
-
A Study on the Efficacy and Safety of Repeated Treatments With Recombinant Botulinum Toxin Type A for Injection in the Treatment of Moderate to Severe Glabellar Lines
NCT06583486 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study to Assess the Adverse Events and Effectiveness of BOTOX Injections for the Treatment of Moderate to Severe Forehead Lines in Chinese Adult Participants
NCT06174688 ·Status: COMPLETED ·Phase: PHASE3
-
To Compare the Safety and Efficacy of "HG-102" With Botox® in the Improvement of Moderate to Severe Glabellar Lines.
NCT04944953 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to Treat Moderate to Severe Glabellar Lines
NCT06937944 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Botulinum Toxin Type A for Injection to Treat Glabellar Lines
NCT02303002 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Of BOTOX For The Treatment Of Glabellar Lines
NCT00408785 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase III Study to Evaluate the Efficacy and Safety of Recombinant Botulinum Toxin Type A for Injection in the Treatment of Moderate to Severe Glabellar Lines
NCT06499688 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of MT10107 in the Treatment of Glabella Line
NCT03908008 ·Status: COMPLETED ·Phase: PHASE3
-
Patient Satisfaction With Treatment of BOTOX® Cosmetic for the Temporary Correction of Moderate to Severe Glabellar Lines
NCT00856414 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess Adverse Events and Effectiveness of OnabotulinumtoxinA Intramuscular Injections for the Change of Moderate to Severe Forehead Lines in Adult Participants
NCT06794866 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Two Types of Botulinum Toxin Type A For the Treatment of Glabellar Lines
NCT01271452 ·Status: COMPLETED ·Phase: PHASE4
-
The Safety and Efficacy Study of PROTOXIN in Subjects With Moderate to Severe Glabellar Lines
NCT04996810 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase I/II Study of Recombinant Botulinum Toxin Type A for the Treatment of Moderate to Severe Glabellar Lines
NCT05743634 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study II
NCT02677805 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines
NCT02493946 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacodynamic and Safety of MT10107(Botulinum Type A Neurotoxin) in Comparison to BOTOX®
NCT03796351 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines
NCT02353871 ·Status: COMPLETED ·Phase: PHASE3
-
Head-to-Head Comparison of All Botulinum Neurotoxin Type A Products for Glabellar Rhytides
NCT06448676 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines
NCT01224015 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Moderate to Severe Glabellar Lines
NCT03216408 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines
NCT05248867 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment With Botulinum Toxin Type A (BOTOX®) in Chinese Patients With Moderate to Severe Frown Lines
NCT01814670 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Investigate the Safety and Efficacy of YY003 in Adults with Moderate to Severe Glabellar Lines
NCT06481475 ·Status: RECRUITING ·Phase: PHASE2
-
BOTOX® in the Treatment of Upper Facial Lines in Japan
NCT01797094 ·Status: COMPLETED ·Phase: PHASE3